GENERATION OF BETA-AMYLOID IN THE SECRETORY PATHWAY IN NEURONAL AND NONNEURONAL CELLS

被引:551
作者
BUSCIGLIO, J
GABUZDA, DH
MATSUDAIRA, P
YANKNER, BA
机构
[1] CHILDRENS HOSP MED CTR,DEPT NEUROL,ENDERS 260,300 LONGWOOD AVE,BOSTON,MA 02115
[2] HARVARD UNIV,SCH MED,DEPT NEUROL,BOSTON,MA 02115
[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115
[4] MIT,WHITEHEAD INST BIOMED RES,DEPT BIOL,CAMBRIDGE,MA 02142
关键词
AMYLOID PRECURSOR PROTEIN; GOLGI COMPLEX; LYSOSOME; ASTROCYTE; ALZHEIMER DISEASE;
D O I
10.1073/pnas.90.5.2092
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The cellular mechanism underlying the generation of beta-amyloid in Alzheimer disease and its relationship to the normal metabolism of the amyloid precursor protein are unknown. In this report, we show that 3- and 4-kDa peptides derived from amyloid precursor protein are normally secreted. Epitope mapping and radiolabel sequence analysis suggest that the 4-kDa peptide is closely related to full-length beta-amyloid and the 3-kDa species is a heterogeneous set of peptides truncated at the beta-amyloid N terminus. The beta-amyloid peptides are secreted in parallel with amyloid precursor protein. Inhibitors of Golgi processing inhibit secretion of beta-amyloid peptides, whereas lysosomal inhibitors have no effect. The secretion of beta-amyloid-related peptides occurs in a wide variety of cell types, but which peptides are produced and their absolute levels are dependent on cell type. Human astrocytes generated higher levels of beta-amyloid than any other cell type examined. These results suggest that beta-amyloid is generated in the secretory pathway and provide evidence that glial cells are a major source of beta-amyloid production in the brain.
引用
收藏
页码:2092 / 2096
页数:5
相关论文
共 33 条
[1]   IMMUNOCHEMICAL IDENTIFICATION OF THE SERINE PROTEASE INHIBITOR ALPHA-1-ANTICHYMOTRYPSIN IN THE BRAIN AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE [J].
ABRAHAM, CR ;
SELKOE, DJ ;
POTTER, H .
CELL, 1988, 52 (04) :487-501
[2]   IMMUNOHISTOCHEMICAL EVIDENCE FOR THE DERIVATION OF A PEPTIDE LIGAND FROM THE AMYLOID BETA-PROTEIN PRECURSOR OF ALZHEIMER-DISEASE [J].
ALLSOP, D ;
WONG, CW ;
IKEDA, S ;
LANDON, M ;
KIDD, M ;
GLENNER, GG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (08) :2790-2794
[3]  
BANKER G, 1991, CULTURING NERVE CELL, P309
[4]   SOLUTION CONFORMATIONS AND AGGREGATIONAL PROPERTIES OF SYNTHETIC AMYLOID BETA-PEPTIDES OF ALZHEIMERS-DISEASE - ANALYSIS OF CIRCULAR-DICHROISM SPECTRA [J].
BARROW, CJ ;
YASUDA, A ;
KENNY, PTM ;
ZAGORSKI, MG .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 225 (04) :1075-1093
[5]   METHODOLOGICAL VARIABLES IN THE ASSESSMENT OF BETA-AMYLOID NEUROTOXICITY [J].
BUSCIGLIO, J ;
LORENZO, A ;
YANKNER, BA .
NEUROBIOLOGY OF AGING, 1992, 13 (05) :609-612
[6]  
CULLEN BR, 1987, METHOD ENZYMOL, V152, P684
[7]   CLEAVAGE OF AMYLOID-BETA PEPTIDE DURING CONSTITUTIVE PROCESSING OF ITS PRECURSOR [J].
ESCH, FS ;
KEIM, PS ;
BEATTIE, EC ;
BLACHER, RW ;
CULWELL, AR ;
OLTERSDORF, T ;
MCCLURE, D ;
WARD, PJ .
SCIENCE, 1990, 248 (4959) :1122-1124
[8]   POTENTIALLY AMYLOIDOGENIC, CARBOXYL-TERMINAL DERIVATIVES OF THE AMYLOID PROTEIN-PRECURSOR [J].
ESTUS, S ;
GOLDE, TE ;
KUNISHITA, T ;
BLADES, D ;
LOWERY, D ;
EISEN, M ;
USIAK, M ;
QU, XM ;
TABIRA, T ;
GREENBERG, BD ;
YOUNKIN, SG .
SCIENCE, 1992, 255 (5045) :726-728
[9]   ALZHEIMERS-DISEASE - INITIAL REPORT OF THE PURIFICATION AND CHARACTERIZATION OF A NOVEL CEREBROVASCULAR AMYLOID PROTEIN [J].
GLENNER, GG ;
WONG, CW .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1984, 120 (03) :885-890
[10]   SEGREGATION OF A MISSENSE MUTATION IN THE AMYLOID PRECURSOR PROTEIN GENE WITH FAMILIAL ALZHEIMERS-DISEASE [J].
GOATE, A ;
CHARTIERHARLIN, MC ;
MULLAN, M ;
BROWN, J ;
CRAWFORD, F ;
FIDANI, L ;
GIUFFRA, L ;
HAYNES, A ;
IRVING, N ;
JAMES, L ;
MANT, R ;
NEWTON, P ;
ROOKE, K ;
ROQUES, P ;
TALBOT, C ;
PERICAKVANCE, M ;
ROSES, A ;
WILLIAMSON, R ;
ROSSOR, M ;
OWEN, M ;
HARDY, J .
NATURE, 1991, 349 (6311) :704-706